Related Experiment Video
Updated: Feb 11, 2026

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Published on: June 7, 2018
Immune-Related Concepts in Biology and Treatment of Germ-Cell Tumors
Michal Chovanec1,2, Ugo De Giorgi3, Michal Mego1
12nd Department of Oncology, Faculty of Medicine, Comenius University, National Cancer Institute, Bratislava, Slovakia.
Abstract:
Germ-cell tumors (GCTs) are highly curable with chemotherapy. Salvage chemotherapy or surgery can cure a proportion of patients, but the ones failing these treatments will die of their disease in the young age. Immune checkpoint pathways are emerging as powerful targetable biomarkers, and a significant preclinical and clinical research is underway to widen our knowledge and expand the treatment possibilities with immune therapy. The concept of immune modulation that was currently adopted in many solid tumors is understudied in GCTs. Herein, we summarize the current knowledge of published literature discussing the immune mechanisms and immune therapy in GCTs.
Insights
Germ-cell tumors (GCTs) are curable, but some patients need advanced treatments. Research is exploring immune modulation and immune checkpoint pathways to improve GCT therapy outcomes.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Germ-cell tumors (GCTs) demonstrate high curability with standard chemotherapy.
- A subset of GCT patients are refractory to salvage chemotherapy or surgery, facing poor prognoses.
- Immune checkpoint pathways are recognized as promising therapeutic targets in oncology.
Purpose of the Study:
- To review the current understanding of immune mechanisms in GCTs.
- To explore the potential of immune modulation and immunotherapy for GCT treatment.
- To identify knowledge gaps and future research directions in GCT immunotherapy.
Main Methods:
- Comprehensive literature search of published studies on GCTs, immune mechanisms, and immunotherapy.
- Synthesis of preclinical and clinical research findings.
- Analysis of immune checkpoint pathway relevance in GCTs.
Main Results:
- Germ-cell tumors (GCTs) are highly curable with chemotherapy, but treatment failures lead to mortality.
- Immune checkpoint pathways represent emerging, targetable biomarkers for GCTs.
- Immune modulation strategies, successful in solid tumors, are under-investigated in GCTs.
Conclusions:
- Further research into immune mechanisms and immunotherapy is crucial for GCT treatment advancement.
- Targeting immune checkpoints holds promise for improving outcomes in refractory GCT cases.
- Exploring immune modulation could expand therapeutic options for patients with germ-cell tumors.
More Related Videos
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11:00Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
Published on: March 25, 2020
Related Concept Videos
Self-Concept
Infancy and Emerging Recognition
During infancy, self-concept is virtually nonexistent. Babies do not distinguish themselves as separate entities and often mistake their...
What is the Immune System?
Concepts and Prototypes
The brain organizes this information using concepts, which are mental categories grouping linguistic data,...
Formula Mass and Mole Concepts of Compounds
Concept of Pressure at a Point
In a fluid at rest, pressure acts equally in...
Understanding Self-Concept